BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 654990)

  • 21. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy].
    Rossi M; Zanardi M
    Clin Ter; 1993 Feb; 142(2):141-4. PubMed ID: 8472528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].
    Serra F; Diaspri GP; Gasbarrini A; Giancane S; Rimondi A; Tamè MR; Sakellaridis E; Bernardi M; Gasbarrini G
    Minerva Med; 1990 Jun; 81(6):465-70. PubMed ID: 2193245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the intrathecal pharmacotherapy. Part I: CDP-choline.
    Ogashiwa M; Takeuchi K; Hara M; Tanaka Y; Okada J
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):327-35. PubMed ID: 1242132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CDP choline and glucose metabolism. Study of clinical pharmacology].
    Angeli G; Moretti GB; Paris B; Bertone V
    Minerva Dietol Gastroenterol; 1985; 31(1):15-20. PubMed ID: 3889717
    [No Abstract]   [Full Text] [Related]  

  • 26. [CDP-choline in the study of somatotropin function in childhood].
    Seminara S; Galluzzi F; Salti R; Chiccoli A; Nania C; La Cauza C
    Minerva Pediatr; 1982 Nov; 34(22):951-4. PubMed ID: 6759913
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of citicoline in high dosages in acute cerebrovascular disease].
    Centrone G; Ragno G; Calicchio G
    Minerva Med; 1986 Mar; 77(11):371-3. PubMed ID: 3703329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytidine diphosphate cholinne -- a new drug in the treatment of spasticity].
    Hernando C; De Blas A; Cubells JM
    Rev Clin Esp; 1978 Nov; 151(4):313-7. PubMed ID: 741011
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diurnal variation of serum cortisol and CDP-choline treatment of patients in the vegetative state].
    Saito Y; Kitane Y; Kawaguchi N; Nojima T; Takahashi
    Horumon To Rinsho; 1975 Oct; 23(10):1021-8. PubMed ID: 1238182
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of cytidine diphosphate choline in acute encephalic lesions].
    de la Herrán J; Cortina C; Salazar J; Fernández de Monge F
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(2):217-26. PubMed ID: 676816
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cerebral protection by CDP choline during surgical action].
    Neidhardt A; Combe M; Combe J; Schipmann N
    Agressologie; 1986 Jun; 27(7):613-5. PubMed ID: 3777355
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [National inquiry on the outcome of severe head injuries: analysis of 921 injured patients treated with CDP-choline].
    Raggueneau JL; Jarrige B
    Agressologie; 1988 May; 29(6):439-43. PubMed ID: 3063125
    [No Abstract]   [Full Text] [Related]  

  • 34. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.
    Franco-Maside A; Caamaño J; Gómez MJ; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):597-607. PubMed ID: 7760585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropsychological study of the senile brain during and after single and combined treatment with deanol and citicoline].
    Bonavita E
    Clin Ter; 1986 Jun; 117(5):387-98. PubMed ID: 3742961
    [No Abstract]   [Full Text] [Related]  

  • 36. [Citicoline activity in senile mental decay].
    Stramba-Badiale M; Scillieri E
    Minerva Med; 1983 Apr; 74(14-15):819-21. PubMed ID: 6835570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of CDP-choline on dynamic changes in LCBF and cognitive function in demented subjects--an H2 15O-PET study].
    Tanaka Y; Minematsu K; Hirano T; Hayashida K; Yamaguchi T
    Rinsho Shinkeigaku; 1994 Sep; 34(9):877-81. PubMed ID: 7820960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double-blind study on the effect of citicholine on the senile brain].
    Bonavita E; Chioma V; Dall'Oca P; Fini C; Michelini M; Ruggi MR; Merli R; Ferro O
    Minerva Psichiatr; 1983; 24(2):53-62. PubMed ID: 6656550
    [No Abstract]   [Full Text] [Related]  

  • 40. [Senile dementia and the cholinergic system: a pharmacologic proposal].
    Tassi C; Pinca L; Calcaterra FM; Santambrogio S
    Minerva Psichiatr; 1983; 24(4):155-8. PubMed ID: 6676621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.